As CCK-8 and colony assays showed, knockdown of ALKBH5 led to the enhanced proliferation capacity in two HCC cells, which could be reverted by LYPD1 silencing (Fig. 7a-d). Here, LYPD1 is linked to hepatocellular carcinoma.